Here you will find the recommendations we have made about the use of individual medicines in Lancashire.


NICE TA: 217
Indication: Alzheimer's Dementia (NICE TA 217)
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No


Treatment should be initiated by specialists in the care of patients with dementia. Prescribing responsibilities can be transferred to primary care after the patient has been established on treatment.


LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

NICE TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Dementia Medicines - Prescribing Information Sheet (in the Guidelines section)

MHRA Drug Safety Update - Rivastigmine (Exelon) transdermal patch: risk of medication errors

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG